BISTTRYOct 5, 18:19Live
KLKIM Price Target 2026Kalekim Kimyevi Maddeler Sanayi ve Ticaret A.Ş.
- Volume
- TRY 21.6M
- Day range
- 22.44 – 23.14
- Previous close
- 22.70
- Market cap
- TRY 10.5B
Last updated: Source: Borsa Istanbul, 15-minute delayed
The average price target of 7 brokers for KLKIM is TRY 52.20 (August 20, 2026), implying 129.34% from the last price.
Broker price targets, buy-hold-sell ratings and model portfolio status for Kalekim Kimyevi Maddeler Sanayi ve Ticaret A.Ş. (KLKIM). The average target is compared with the current price to derive the implied upside; the AI fair value estimate is shown for comparison.
Last updated: Source: Broker research
Analyst Consensus
- Average target
- 52.20 TL
- Median target
- 52.44 TL
- Highest target
- 60.50 TL
- Lowest target
- 39.65 TL
- Upside
- 129.34%
- Buy / Hold / Sell
- 5 / 1 / 0
Broker Price Targets
| Broker | Date | Rating | Target price | Upside |
|---|---|---|---|---|
 Ak Yatirim | August 20, 2026 | Outperform | 59.00 | 159.23% |
 Deniz | August 19, 2026 | Buy | 54.00 | 137.26% |
 Gedik | August 19, 2026 | Market perform | 39.65 | 74.21% |
 Alnus | August 19, 2026 | Buy | 48.00 | 110.90% |
 Oyak | August 4, 2026 | Outperform | 52.44 | 130.40% |
 Info | February 12, 2026 | ÖNERİ YOK | 51.80 | 127.59% |
 Anadolu | January 29, 2026 | Buy | 60.50 | 165.82% |
AI Fair Value
- AI fair value
- 24.55 TL
- Upside
- 7.87%
- Model date
- July 21, 2026
Frequently Asked Questions
How many brokers have a price target for KLKIM?
7 brokers have an average target of TRY 52.20 for KLKIM, with 5 buy, 1 hold and 0 sell ratings.
What are the highest and lowest price targets for KLKIM?
The highest price target for KLKIM is TRY 60.50, the lowest is TRY 39.65 and the median is TRY 52.44.
What is the AI price target for KLKIM?
Our AI fair value model estimates TRY 24.55 for KLKIM, a difference of 7.87% from the current price. The model was updated on July 21, 2026. Not investment advice.
Is a price target investment advice?
No. Price targets are opinions from broker research reports, provided for information only, not a recommendation to buy or sell.